Keywords: Onyx Pharma, Trxas MD Anderson Cancer Center, Research alliance, Carfilzomib, Oprozomib

Onyx Pharma links with Texas MD Anderson Cancer Center on research

Article | 05 June 2012

Print This

US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) and The University of Texas MD Anderson Cancer Center have announced a non-exclusive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in